Apixaban 2.5 milligram Oral Tablet

DRUG2 trials

Conditions

Atrial FibrillationCardiovascular ComplicationChronic Kidney DiseasesDeathHemodialysis ComplicationIntracerebral HemorrhageKidney Transplant; ComplicationsMajor Bleed

Phase 2

Study of Apixaban in Patients Receiving Hemodiafiltration

CompletedNCT04952792

Hospital Universitari de BellvitgeAtrial Fibrillation, Hemodialysis Complication

Start: 2021-05-20End: 2022-12-15Updated: 2023-09-21

Phase 3

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

RecruitingNCT05679024

Region StockholmAtrial Fibrillation, Cardiovascular Complication, Chronic Kidney Diseases +6

Start: 2023-02-17End: 2028-12-31Target: 1400Updated: 2024-10-04

Apixaban 2.5 milligram Oral Tablet

Sponsors

Conditions

Phase 2

Phase 3